/------------------------------/
                                               /        OMB APPROVAL          /
                                               /------------------------------/
                                               / OMB Number:        3235-0287 /
                                               / Expires: January 31, 2005    /
                                               / Estimated average burden     /
                                               / hours per response...... 0.5 /
                                               /------------------------------/

 +--------+                         U.S. SECURITIES AND EXCHANGE COMMISSION
 | FORM 4 |                                      WASHINGTON, D.C. 20549
 +--------+
 [_] Check this box if
     no longer subject         STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
     to Section 16.
     Form 4 or Form 5        Filed pursuant to Section 16(a) of the Securities
     obligations may         Exchange Act of 1934, Section 17(a) of the
     continue. See           Public Utility Holding Company Act of 1935 or
     Instruction 1(b)        Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
- --------------------------------------------------------------------------------
1.  Name and Address of Reporting Person*
        Stark,                     Stevan                             R.
- --------------------------------------------------------------------------------
        (Last)                      (First)                        (Middle)

                  c/o Laboratory Corporation of America
                         430 South Spring Street
- --------------------------------------------------------------------------------
                                   (Street)

     Burlington                   North Carolina                      27215
- --------------------------------------------------------------------------------
        (City)                      (State)                           (Zip)
- --------------------------------------------------------------------------------
2.  Issuer Name and Ticker or Trading Symbol

Laboratory Corporation of America Holdings("LH")
- --------------------------------------------------------------------------------
3.  I.R.S. Identification Number of Reporting Person, if an entity
    (voluntary)
               ---------------------------
4.  Statement for Month/Year     March 2002
                            ----------------------------------------------------
5.  If Amendment, Date of Original (Month/Year)
                                               ---------------------------------
6.  Relationship of Reporting Person(s) to Issuer (Check all applicable)
    ___ Director             ___ 10% Owner  (give title below)

     X  Officer              ___ Other (specify below)
    ---
        Executive Vice President
    ----------------------------------------------------------------
7.  Individual or Joint/Group Filing (Check Applicable Line)
     X   Form filed by One Reporting Person
    ---
    ____ Form filed by More than One Reporting Person

Table I--Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

- ------------------------------------------------------------------------------------------------------------------------------------ 1. Title 2. Trans- 3. Trans- 4. Securities Acquired (A) 5. Amount of 6. Owner- 7. Nature of action action or Disposed of (D) Securities ship of In- Security Date Code (Instr. 3, 4 and 5) Beneficially Form: direct (Instr. 3) (Month/ (Instr. 8) Owned at Direct Bene- Day/ ----------------------------------------------- End of (D) or ficial Year) Month Indirect Owner- Code V Amount (A) or Price (Instr. 3 and 4) (I) ship (D) (Instr. 4) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 3/15/02 F V 9,300 D $90.90 71,016.3570 D - ------------------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------
Table II--Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
- ----------------------------------------------------------------------------------------------------------------------------- 1. Title of Derivative 2. Conver- 3. Trans- 4. Transac- 5. Number of Deriv- Security (Instr. 3) sion or action tion Code ative Securities Exercise Date (Instr. 8) Acquired (A) or Price of (Month/ Disposed of (D) Deriv- Day/ (Instr. 3, 4, and 5) ative Year) Security --------------------------------------------------- Code V (A) (D) - ----------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------- - -----------------------------------------------------------------------------------------------------------------------------
Table II--Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
- ------------------------------------------------------------------------------------------------------------------------------------ 6. Date Exer- 7. Title and Amount of 8. Price 9. Number 10. Owner- 11. Na- cisable and Underlying Securities of of Deriv- ship ture Expiration (Instr. 3 and 4) Deriv- ative Form of In- Date ative Secur- of De- direct (Month/Day/ Secur- ities rivative Bene- Year) ity Bene- Securities ficial (Instr. ficially Bene- Owner- -------------------------------------------- 5) Owned ficially ship Date Expira- Amount or at End Owned at (Instr. Exer- tion Title Number of of End of 4) cisable Date Shares Month Month(1) (Instr. 4) (Instr. 4) - ------------------------------------------------------------------------------------------------------- - ------------------------------------------------------------------------------------------------------- - ------------------------------------------------------------------------------------------------------- - ------------------------------------------------------------------------------------------------------- - ------------------------------------------------------------------------------------------------------- - -------------------------------------------------------------------------------------------------------
Explanation of Responses: /s/ Bradford T. Smith ------------------------------- **Signature of Reporting Person April 8, 2002 Bradford T. Smith, Attorney-in-Fact for ------------- Date Stevan R. Stark Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure